DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Romeo D, Sismondi P, Giai M, Genta F, Pacini P, Distante V, Bolognesi A, Aldrighetti D, Farris A.
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial.
J Clin Oncol 2000; 18: 2718-2727
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.